HPV Testing
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Pragmatic Mobile Health Trial to Promote Cancer Screening and Healthy Behaviors
Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity
Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand
Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis
Screening Triage and Risk Stratification
HPV Screening (Human Papilloma Virus)